GALWAY, Ireland – Medtronic has submitted 510 (k) applications to the U.S. Food and Drug Administration seeking clearance for an interoperable pump. FDA clearance of this pump would pave the way for ...

GALWAY, Ireland, April 24, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has submitted 510(k) applications to the U.S. Food and Drug ...

Right: Medtronic’s MiniMed 780G. [Image courtesy of the companies] Medtronic (NYSE:MDT) announced today that it submitted 510 (k) applications to the FDA seeking clearance for an interoperable insulin ...

Affecting all lots, serial numbers, and these models of the MiniMed 630G, 670G, 770G, and 780G products, the portable pumps have an increased risk for reduced battery life and a shorter time until ...

On Oct. 4, Medtronic notified users of the 630G, 670G, 770G and 780G insulin pumps of an increased risk for shorter-than-expected battery life and less time until the pump shuts down following a ...

Medtronic has issued a second alert letter to patients regarding shortened battery life of the MiniMed 600 and 700 series insulin pumps. The affected products include the MiniMed 630G, 670G, 770G ...

Customers are being notified of the importance of checking built-in alerts and alarms for battery status and to contact Medtronic for pump replacement if affected by this issue. GALWAY, Ireland ...

Medtronic plc MDT initiated a recall Friday to address potential battery life issues with its insulin pumps. As of July 31, the company has advised customers to pay close attention to their pumps ...

GALWAY, Ireland, Oct. 4, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, voluntarily issued a field action starting on July 31, 2024, notifying global ...

The pairing of Abbott's leading FreeStyle Libre technology with Medtronic's AID algorithms could enable automatic insulin adjustment for Type 1 and Type 2 diabetics to keep glucose in range.